The objective of the this surveillance is to collect information about 1)adverse drug
reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of
adverse drug reactions in this surveillance, and 3) factors considered to affect the safety
and/or efficacy of this drug.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.